Expanded Access Multicenter Study of Lucanix (Belagenpumatucel-L) in Advanced Non-small Cell Lung Cancer.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 28 Feb 2011
At a glance
- Drugs Belagenpumatucel-L (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 28 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 27 Jan 2011 New trial record